BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 9060044)

  • 1. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.
    Horn DL; Opal SM; Lomastro E
    Scand J Infect Dis Suppl; 1996; 101():9-13. PubMed ID: 9060045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC
    Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
    Morrison DC
    Prog Clin Biol Res; 1998; 397():199-207. PubMed ID: 9575560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
    Opal SM; Palardy JE; Parejo N; Morrison DC
    J Endotoxin Res; 2001; 7(1):35-8. PubMed ID: 11521079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An experimental study of the LPS release from gram-negative bacteria induced by antibiotics (Part two)].
    Xu N; Yuan J; Xiao G; Zheng J; Qin X
    Zhonghua Shao Shang Za Zhi; 2002 Apr; 18(2):92-4. PubMed ID: 12515654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxemia induced by antibiotic therapy: a mechanism for adrenal corticosteroid protection in gram-negative sepsis.
    Johnston CA; Greisman SE
    Trans Assoc Am Physicians; 1984; 97():172-81. PubMed ID: 6398946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis.
    Bucklin SE; Morrison DC
    J Infect Dis; 1995 Dec; 172(6):1519-27. PubMed ID: 7594711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of the induction of inflammatory mediators by antibiotics in mouse macrophages in response to viable Gram-positive and Gram-negative bacteria.
    Cui W; Lei MG; Silverstein R; Morrison DC
    J Endotoxin Res; 2003; 9(4):225-36. PubMed ID: 12935353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of egg white lysozyme on ceftazidime-induced release of endotoxin from Pseudomonas aeruginosa].
    Liang AH; Xue BY; Liang RX; Wang JH; Wang D
    Yao Xue Xue Bao; 2003 Nov; 38(11):801-4. PubMed ID: 14991988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an anti-endotoxin vaccine for sepsis.
    Cross AS
    Subcell Biochem; 2010; 53():285-302. PubMed ID: 20593272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytes.
    Busch CJ; Wanner GA; Menger MD; Vollmar B
    Inflamm Res; 2004 May; 53(5):205-10. PubMed ID: 15105970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
    Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
    J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.